Posts With Tag NASDAQ ARWR

Showing 1 - 1 of 1 Post

Arrowhead Pharmaceuticals 8-K Report: Key Developments on December 11, 2024

•

Form 8-K

•

2024-12-18

Last updated: 5 months ago

Arrowhead Pharmaceuticals 8-K Report: Key Developments on December 11, 2024

Discover the latest insights from Arrowhead Pharmaceuticals' 8-K filing, detailing crucial events and updates for investors on December 11, 2024.

Arrowhead Pharmaceuticals Pharmaceuticals NASDAQ ARWR 8-K Filing Investor Relations